MARGUGLIO DAVID J. (Sr VP of Business Development) exercised options at DMK PHARMACEUTICALS CORP
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/23/2021ACC: 0001593968-21-000579
DirectorOfficer· Sr VP of Business Development
Since Jan 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
22.26K acquired · 22.26K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.26K
Price / share
—
Trade value
—
% of position
7.7%
2/21/2021
287.26K→309.52K
Total
Net shares
+22.26K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2021 | M · Option Exercise | +22.26K | — | — | 7.7% | 287.26K | 309.52K |
| Total | +22.26K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
22.26K shares
Shares
−22.26K
Strike price
Held after
0.00
Exercisable
—
2/21/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock22.26K shares | 2/21/2021 | M · Option Exercise | −22.26K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.88K
Total
5.88K indirect5.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.88K | Indirect |
| Total | 5.88K | 5.88K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported